Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Leukemia Drugs News Monitoring

Get by Email • RSS

Published on May 28, 2025

Kevin L. Hagan with PAN Foundation Discusses The Hidden Health Crisis: When Treatment Costs Break the Bank with ...

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- We often hear that healthcare is personal—but for millions of Americans, it’s also financially devastating. New research from the PAN Foundation’s Center for Patient Research reveals a quiet crisis with massive …

Distribution channels: Media, Advertising & PR ...
Published on May 31, 2025

The Phase 2 Trial for CD5-Directed CAR-T MB-105 in R/R T-Cell Lymphoma

March Biosciences is currently developing MB-105, an investigational CD5-directed chimeric antigen receptor T-cell (CAR-T) therapy, with the intent of addressing unmet needs in the treatment of relapsed/refractory (r/r) CD5-positive T-cell lymphoma …

Source: CGTLive - Neutral
Published on May 31, 2025

Busting cancer myths: Why delay can be deadly in India’s fight against the disease

With over 100,000 cancer cases reported annually, India faces a growing health crisis worsened by myths, stigma and misinformation. Firstpost presents the expert’s view to debunk common misconceptions around causes and treatments—from family history to CAR …

Source: Firstpost - Center-right
Published on May 30, 2025

First Patient Treated in Second Cohort of STARLIGHT-1 B-Cell NHL Trial

The phase 1/2 STARLIGHT-1 trial has dosed the first patient in the second cohort of the dose escalation study which is evaluating the CD19-redirected Artemis T-cell therapy, EB103, for the treatment of patients with advanced B-cell non-Hodgkin …

Source: Cure Today - Neutral
Published on May 30, 2025

Auron doses first subject in AUTX-703 trial for haematologic malignancies

Auron Therapeutics has dosed the first subject in the multicentre Phase I trial of the orally available lysine acetyltransferase 2A (KAT2A) and lysine acetyltransferase 2B (KAT2B) degrader, AUTX-703, targeting individuals with advanced haematologic …

Source: Clinical Trials Arena - Pending
Published on May 30, 2025

Jakafi Shows Some Promise for Preventing Chronic GVHD

The FDA and the European Medicines Agency have approved Jakafi (ruxolitinib) as a second-line treatment for acute and chronic graft-versus-host disease (GVHD) that hasn’t responded to corticosteroids. But positive results of a phase 2 trial suggest that …

Source: Managed Healthcare Executive - Neutral
Published on May 30, 2025

Continuing Ponatinib Benefits Patients Without Early MRD Negativity in Ph+ ALL

The phase 3 PhALLCON trial (NCT03589326) initially showed that ponatinib (Iclusig) led to significantly higher rates of measurable residual disease (MRD) negativity with complete remission compared to imatinib (Gleevec) in patients with newly diagnosed …

Source: Targeted Oncology - Pending
Published on May 30, 2025

Innovative Immunotherapy Shows Promise Against Aggressive T Cell Cancers

Newswise — A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led by researchers at Washington University …

Source: Newswise - Neutral
Published on May 30, 2025

Sarvodaya Hospital, Faridabad, opens Theranostics Centre, offers Terbium-161 PSMA Therapy

Sarvodaya Hospital, Faridabad, Delhi NCR, inaugurates its Theranostics and Nuclear Medicine centre in India to offer Terbium-161 PSMA therapy for prostate cancer treatment. The centre offers treatment to patients with advanced metastatic castration …

Source: Express Healthcare - Neutral
Published on May 30, 2025

Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis

Pelabresib (CPI-0610) treatment in combination with Rituxan (ruxolitinib) was found to be safe, well tolerated, and improved signs of underlying myelofibrosis pathobiology, as well as provided substantial clinical benefit over standard-of-care therapy with …

Source: Cure Today - Neutral
Published on May 29, 2025

Real-World Data Reveal Higher Risk of Serious Infections in Patients With CLL/SLL

Photo Credit: Wildpixel A real-world study, presented at ASCO 2025, used data from the Symphony Health Solutions database to assess the incidence of serious infections in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/ …

Source: Physician's Weekly - Neutral
Published on May 29, 2025

Faridabad's Sarvodaya Hospital offers Terbium-161 PSMA Therapy for Prostate Cancer

Faridabad: In a landmark development for cancer treatment in India, Sarvodaya Hospital, Faridabad, has become the country’s first theranostics and nuclear medicine centre to offer Terbium-161 PSMA therapy for patients battling advanced prostate cancer. …

Source: ETHealthworld.com - Center-right
Published on May 29, 2025

John Theurer Cancer Center Presents Innovative Cancer Research at Major Annual Cancer Meeting, Offering New Hope for ...

Newswise — Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—part of the National Cancer Institute-designated Lombardi Comprehensive Cancer Center at Georgetown University—and Hackensack University Medical Center are reporting …

Source: Newswise - Neutral
Published on May 29, 2025

Unique Diagnostic Profile for BPDCN Warrants Focus on Hematopathology

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a hematologic malignancy with poor outcomes, which can be challenging to diagnose due to its rarity and indistinct skin manifestations. In a recent virtual Case-Based Roundtable meeting that brought …

Source: Targeted Oncology - Pending
Published on May 29, 2025

Triplet Therapy Shows Promise in High-Risk Relapsed CLL

The measurable residual disease (MRD)-guided triplet combination of zanubrutinib (Brukinsa), venetoclax (Venclexta), and obinutuzumab (Gazvya) led to deep remissions in patients with relapsed chronic lymphocytic leukemia (CLL), especially in a population …

Source: Targeted Oncology - Pending
Published on May 28, 2025

HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds

Preclinical data has shown compelling findings for HT-KIT, a proprietary antisense oligonucleotide therapy designed to silence aberrant KIT gene expression, among patients with rare and aggressive KIT-driven cancers, according to a news release from Hoth …

Source: Cure Today - Neutral
Published on May 28, 2025

Rebuilding Resilience: Navigating Aging and Exercise After CLL

In 2017, at age 67, I completed the Boston Marathon in under four hours. Despite the achievement, I noticed a shift — my recovery times lengthened, and my running pace slowed. This marked the beginning of a new chapter in my fitness journey, one influenced …

Source: Cure Today - Neutral
Published on May 28, 2025

$400,000 Prize Honors Pioneers of CAR T-Cell Therapy

The 2025 Richard N. Merkin Prize in Biomedical Technology has been awarded to Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain for their foundational contributions to the development of CAR T-cell therapy. The recipients were jointly honored …

Source: The Medicine Maker - Neutral
Published on 09:13 GMT

Biophysicist Dr. James Till co-discovered stem cells, sparking a medical revolution

Open this photo in gallery:James Till at the Princess Margaret Cancer Centre in Toronto on Dec. 14, 2017.Laura Pedersen/University Health Network Canadian biophysicist James Till, who changed the future of medicine by proving the existence of stem …

Source: The Globe and Mail - Neutral

29 days 20:16:26

Featured Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 11:28 GMT

In-Depth Analysis Of The Global Pharma And Biotech Crm Software Market: Key Drivers, Trends, And Forecast 2025-2034

The Business Research Company's Pharma And Biotech CRM Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:03 GMT

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP as Chief Medical Officer. Dr. Andrews …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 12:00 GMT

SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma ...

Financing supports SpyGlass Pharma’s platform through the readout of two Phase III pivotal trials ALISO VIEJO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a privately held ophthalmic biotechnology company, today announced the closing of a $ …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 11:00 GMT

NervGen Pharma Reports Positive Topline Data from the Chronic Cohort of its Phase 1b/2a Clinical Trial Evaluating NVG-...

Study met its primary endpoint by achieving statistical significance on one of its two pre-specified co-primary endpoints, demonstrating increased electrical connectivity between the brain and hand muscle in individuals with a cervical level spinal cord …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 11:00 GMT

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory ...

--Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi -- REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well tolerated in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 12:00 GMT

Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference

CONSHOHOCKEN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the 46th Annual Global Goldman Sachs Health Care Conference on Wednesday, June 11, 2025 at 10:40 A.M. …

Distribution channels:
Published on June 2, 2025 - 11:00 GMT

Sanofi Exercises License Extension Option to Nurix’s STAT6 Program

STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions Nurix to receive a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:46 GMT

URGN STOCK: Suffer Losses on UroGen Pharma Ltd.? BFA Law Notifies Investors of Imminent July 28 Securities Class Action ...

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …

Distribution channels: Consumer Goods, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 818,261,502 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 13:05 GMT

Global Dysport Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends

The Business Research Company's Dysport Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- In the past few years, the Dysport market has …

Distribution channels: Business & Economy, Companies ...
Published on June 2, 2025 - 13:00 GMT

Buscar Company Acquires 70% Stake in Armorgenix

Buscar Company (OTCMKTS:CGLD) BEVERLY HILLS, CA, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Buscar Company Acquires 70% Stake in Armorgenix, Bolstering Portfolio with Pharmaceutical Innovation and Positioning for Growth in the U.S. Antiviral …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 2, 2025 - 13:00 GMT

EcoFam Introduces Consumers to New Hydroxyapatite Toothpaste Tablets

Toothpaste Tablets Are a Sustainable, Fun, And Easy Way to Clean Your Teeth OREM, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Most Americans are used to brushing their teeth with a paste or gel dispensed from a plastic tube. Although …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on June 2, 2025 - 12:53 GMT

Deep Brain Stimulation Devices Market estimated to reach US$3,237.249 million by 2030 at a CAGR of 10.33%

The deep brain stimulation devices market is anticipated to grow at a CAGR of 10.33% from US$1,979.749 million in 2025 to US$3,237.249 million by 2030. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- According to a new study …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:45 GMT

Surgical Trocars Market Expansion Outlook 2024-2031 | DataM Intelligence – Smart Data, Smarter Decisions

The Surgical Trocars Market is set for steady growth through 2031, driven by rising demand for minimally invasive surgeries and advanced surgical tools. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Surgical Trocars Market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:45 GMT

Digital Dose Inhalers Market Growth 2024 - 2031 | Insights By DataM Intelligence - Your Partner in Data-Driven Insights

The Digital Dose Inhalers Market is set for strong growth through 2031, driven by rising respiratory diseases and demand for smart, accurate drug delivery. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Digital Dose Inhalers Market …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:42 GMT

Global Hydrolyzed Vegetable Proteins Market Outlook 2025-2034: Growth Drivers, Share, And Trends

The Business Research Company’s Hydrolyzed Vegetable Proteins Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The hydrolyzed vegetable proteins …

Distribution channels: Business & Economy, Consumer Goods ...
Published on June 2, 2025 - 12:42 GMT

Food And Beverages Market Report 2025: Size, Trends, And Growth Insights For Global Expansion

The Business Research Company’s Food And Beverages Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The food and beverages market size has grown …

Distribution channels: Business & Economy, Consumer Goods ...
Published on June 2, 2025 - 12:36 GMT

Eyewear Global Market Report 2025: Strong Market Growth Predicted With Trends and Drivers

The Business Research Company’s Eyewear Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest Report …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:30 GMT

Stuttering Devices Market to Reach $108B by 2031, Fueled by Technology & Awareness Growth | DataM Intelligence

The future of fluent speech: Global demand for stuttering devices is reshaping therapy, tech, and accessibility. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Stuttering Devices Market is experiencing robust and sustained growth. …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:30 GMT

Future of Diabetes Care: Tubeless Insulin Pump Market to Reach $9.65B by 2031 | DataM Intelligence

Explore the booming tubeless insulin pump market, projected to reach USD 9.65B by 2031, driven by innovation and rising global diabetes prevalence. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The tubeless insulin pump market was valued …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:30 GMT

HbA1c Testing Device Market Set to Surge with 10.6% CAGR Through 2033 | DataM Intelligence

The HbA1c Testing Device Market, valued at US$ 2.01 billion in 2024, is projected to hit US$ 5.69 billion by 2033, growing at a CAGR of 10.6%. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Market Overview : The HbA1c Testing Device …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:30 GMT

Nuclear Imaging Equipment Market to Reach $5.46B by 2031 Amid Rising Chronic Disease & Tech | DataM Intelligence

Nuclear Imaging Equipment Market is set to grow to $5.46B by 2031, driven by tech advances, rising chronic diseases, and expanding global healthcare needs. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Nuclear Imaging Equipment …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:18 GMT

Key Trend in Postpartum Depression Treatment 2025: Advancing Diagnosis And Care via Integrated Therapeutic Modalities

The Business Research Company's Postpartum Depression Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:12 GMT

Left Atrial Appendage Closure Device Market projected to surpass US$ 8,786.032 million by 2030 at a CAGR of 20.39%

The left atrial appendage closure device market is anticipated to grow at a CAGR of 20.39% from US$ 3,473.731 million in 2025 to US$ 8,786.032 million by 2030. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- According to a new …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:11 GMT

Leading Driver in the Posture Correction Market 2025: Surge in Spinal And Back Disorders Boosting Market Growth

The Business Research Company's Posture Correction Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:11 GMT

Global Pressure Ulcers Market: Key Trends, Market Share, Growth Drivers, and Forecast for 2025-2034

The Business Research Company's Pressure Ulcers Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:10 GMT

Global Preterm Birth Prevention Market 2025-2034: Growth Drivers, Key Segments, and Emerging Trends

The Business Research Company's Preterm Birth Prevention And Management Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:09 GMT

Exploring the Growth of the Primary Immunodeficiency Disorders Global Market: A Forecast through 2025

The Business Research Company's Primary Immunodeficiency Disorders Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 12:00 GMT

AB Global Unveils the KnOWLedge Vault: A Bold Leap in Compliance Excellence

AB Global, The Gold Standard in Background Screening Unveils the KnOWLedge Vault: A Bold Leap Forward in Compliance Excellence,Where Compliance Meets Confidence ST. PETERSBURG, FL, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- AB Global, The …

Distribution channels: Building & Construction Industry, Business & Economy ...